Back to mobile site

Form SCHEDULE 13G Eloxx Pharmaceuticals, Filed by: Coastlands Capital LP

May 1, 2026 9:55 PM EDT





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  Consists of 1,250,000 shares of Common Stock held directly by Coastlands Capital LP. The calculation of the beneficial ownership of the Reporting Persons is based on (A) 5,071,935 shares outstanding as of March 12, 2026, as disclosed in the Annual Report on Form 10-K for the year ended December 31, 2025 filed by the Issuer on March 17, 2026 and (B) 2,500,000 shares of Common Stock issued on April 27, 2026 to certain holders upon the exercise of pre-funded warrants. Excludes shares of Common Stock issuable upon the exercise of pre-funded warrants held by the Reporting Persons in excess of a beneficial ownership limitation of 4.99%.


SCHEDULE 13G




Comment for Type of Reporting Person:  Consists of 1,250,000 shares of Common Stock held directly by Coastlands Capital LP. The calculation of the beneficial ownership of the Reporting Persons is based on (A) 5,071,935 shares outstanding as of March 12, 2026, as disclosed in the Annual Report on Form 10-K for the year ended December 31, 2025 filed by the Issuer on March 17, 2026 and (B) 2,500,000 shares of Common Stock issued on April 27, 2026 to certain holders upon the exercise of pre-funded warrants. Excludes shares of Common Stock issuable upon the exercise of pre-funded warrants held by the Reporting Persons in excess of a beneficial ownership limitation of 4.99%.


SCHEDULE 13G




Comment for Type of Reporting Person:  Consists of 1,250,000 shares of Common Stock held directly by Coastlands Capital LP. The calculation of the beneficial ownership of the Reporting Persons is based on (A) 5,071,935 shares outstanding as of March 12, 2026, as disclosed in the Annual Report on Form 10-K for the year ended December 31, 2025 filed by the Issuer on March 17, 2026 and (B) 2,500,000 shares of Common Stock issued on April 27, 2026 to certain holders upon the exercise of pre-funded warrants. Excludes shares of Common Stock issuable upon the exercise of pre-funded warrants held by the Reporting Persons in excess of a beneficial ownership limitation of 4.99%.


SCHEDULE 13G




Comment for Type of Reporting Person:  Consists of 1,250,000 shares of Common Stock held directly by Coastlands Capital LP. The calculation of the beneficial ownership of the Reporting Persons is based on (A) 5,071,935 shares outstanding as of March 12, 2026, as disclosed in the Annual Report on Form 10-K for the year ended December 31, 2025 filed by the Issuer on March 17, 2026 and (B) 2,500,000 shares of Common Stock issued on April 27, 2026 to certain holders upon the exercise of pre-funded warrants. Excludes shares of Common Stock issuable upon the exercise of pre-funded warrants held by the Reporting Persons in excess of a beneficial ownership limitation of 4.99%.


SCHEDULE 13G




Comment for Type of Reporting Person:  Consists of 1,250,000 shares of Common Stock held directly by Coastlands Capital LP. The calculation of the beneficial ownership of the Reporting Persons is based on (A) 5,071,935 shares outstanding as of March 12, 2026, as disclosed in the Annual Report on Form 10-K for the year ended December 31, 2025 filed by the Issuer on March 17, 2026 and (B) 2,500,000 shares of Common Stock issued on April 27, 2026 to certain holders upon the exercise of pre-funded warrants. Excludes shares of Common Stock issuable upon the exercise of pre-funded warrants held by the Reporting Persons in excess of a beneficial ownership limitation of 4.99%.


SCHEDULE 13G



 
Coastlands Capital LP
 
Signature:/s/ Mark Shamia
Name/Title:Chief Operating Officer of the General Partner, Coastlands Capital LLC
Date:05/01/2026
 
Coastlands Capital Partners LP
 
Signature:/s/ Mark Shamia
Name/Title:Chief Operating Officer of the General Partner, Coastlands Capital GP LLC
Date:05/01/2026
 
Coastlands Capital GP LLC
 
Signature:/s/ Mark Shamia
Name/Title:Chief Operating Officer
Date:05/01/2026
 
Coastlands Capital LLC
 
Signature:/s/ Mark Shamia
Name/Title:Chief Operating Officer
Date:05/01/2026
 
Matthew D. Perry
 
Signature:/s/ Matthew D. Perry
Name/Title:Reporting Person
Date:05/01/2026

Comments accompanying signature:  Exhibit 99.1 - Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G
Exhibit Information

Exhibit 99.1 - Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G

ATTACHMENTS / EXHIBITS

EXHIBIT 99.1



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings

Related Entities

13G